Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021

• DOI: 10.1016/j.rmr.2021.02.070
• Publication Date: 2021-05-10T22:24:03Z
• Authors: M. Zysman; B. Ribeiro Baptista; T. Soumagne; V. Marques da Silva; C. Martin; C. Thibault de Me...; L. Boyer; B. Degano; C. Morelot Panzini; P.R. Burgel; T. Perez; A. Bourdin; C. Raherison; H. Pégliasco; D. Piperno; C. Zanetti; H. Morel; B. Delclaux; C. Delafosse; A. Lorenzo; B. Housset; F. Chabot; P. Devillier; G. Deslée; N. Roche
• Keywords: [SDV] Life Sciences [q-bio]; Pulmonary Disease, Chronic Obstructive; 03 medical and health sciences; 0302 clinical medicine; [SDV]Life Sciences [q-bio]; Humans; [SHS]Humanities and Social Sciences; Language

International audience